Earnings Feed
Start Free
Home/Filings/4/0001140361-09-006488
4//SEC Filing

ELLISON DAVID J 4

Accession 0001140361-09-006488

CIK 0000872947other
View on SEC.govCompany Profile

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 11:43 AM ET

Size

22.3 KB

Accession

0001140361-09-006488

Insider Transaction Report

Form 4
Period: 2009-03-06
APPLIED NEUROSOLUTIONS INCAPNS
ELLISON DAVID J
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option

    2009-03-06−35,656→ 0 total
    Exercise: $0.15From: 2005-06-01Exp: 2012-06-01→ Common Stock (35,656 underlying)
  • Award

    Stock Option

    2009-03-06+11,885→ 11,885 total
    Exercise: $0.05From: 2009-03-06Exp: 2012-06-01→ Common Stock (11,885 underlying)
  • Disposition to Issuer

    Stock Option

    2009-03-06−164,599→ 0 total
    Exercise: $0.15From: 2004-11-01Exp: 2011-11-01→ Common Stock (164,599 underlying)
  • Disposition to Issuer

    Stock Option

    2009-03-06−500,000→ 0 total
    Exercise: $0.15From: 2006-09-02Exp: 2013-09-02→ Common Stock (500,000 underlying)
  • Award

    Stock Option

    2009-03-06+54,866→ 54,866 total
    Exercise: $0.05From: 2009-03-06Exp: 2011-11-01→ Common Stock (54,866 underlying)
  • Disposition to Issuer

    Stock Option

    2009-03-06−69,132→ 0 total
    Exercise: $0.15From: 2003-11-16Exp: 2010-11-16→ Common Stock (69,132 underlying)
  • Award

    Stock Option

    2009-03-06+23,044→ 23,044 total
    Exercise: $0.05From: 2009-03-06Exp: 2010-11-16→ Common Stock (23,044 underlying)
  • Award

    Stock Option

    2009-03-06+166,667→ 166,667 total
    Exercise: $0.05From: 2009-03-06Exp: 2013-09-02→ Common Stock (166,667 underlying)
Footnotes (4)
  • [F1]Grant under issuer's 2003 Stock Option Plan in connection with exchange of options described in Note 2 below.
  • [F2]Reporting Person returned these stock options to the Registrant and received 1 new option for every 3 existing options returned.
  • [F3]The vesting and expiration of the new options on the transaction date are the same as the vesting and expiration of the exchanged options.
  • [F4]Exercise price is a 25% premium to market ($0.01 premium).

Documents

1 file

Issuer

APPLIED NEUROSOLUTIONS INC

CIK 0000872947

→
Entity typeother

Related Parties

1
  • filerCIK 0001263234

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 11:43 AM ET
Size
22.3 KB
View on SEC.gov